BioXGEM.
KIDFamMap
Home
Example1
Example2
Statistics
Document
Contact US
Diseases
Inhibitor-Anchor Map
Family Anchors
Kinase-Inhibitor Family
Template
Protein
Surface
Ribbon
Inhibitor
ATP Location
Pocket
ATP
NLP
HAP
CLP
SP
Summary of query kinase
Query kinase
TIE1 (
P35590
)
Kinase group
TK
Number of conformation types
0
Number of structural templates
52 (
Total 73 inhibitors
)
Select
Template
Comformation
Type
No. of
Templates
Representative
Template
Kinase
Group
Representative
Inhibitor
Inhibitor
Type
No. of
Kinases
No. of
Inhibitors
No. of
Diseases
A
14
1XJDA_STU
(PRKCQ)
TK
staurosporine
I
121
101
106
A
1XJDA_STU
(PRKCQ)
TK
staurosporine
I
121
101
106
121
101
106
A
1YVJA_4ST
(JAK3)
TK
staurosporine
I
96
90
126
96
90
126
A
2HZ4A_4ST
(ABL1)
TK
staurosporine
I
159
103
156
159
103
156
A
3CKXA_STU
(STK24)
TK
staurosporine
I
176
104
141
176
104
141
A
1SM2A_STU
(ITK)
TK
staurosporine
I
99
104
128
99
104
128
A
1SNUA_STU
(ITK)
TK
staurosporine
I
99
104
128
99
104
128
A
2F4JA_VX6
(ABL1)
TK
VX-680
I
110
109
134
110
109
134
A
2XYNA_VX6
(ABL2)
TK
VX-680
I
79
101
105
79
101
105
A
2JEDA_LG8
(PRKCQ)
TK
5-Arylidene-...
I
67
19
87
67
19
87
A
1OPLA_P16
(ABL1)
TK
PD166326
I
89
70
123
89
70
123
A
2FO0A_P16
(ABL1)
TK
PD166326
I
89
70
123
89
70
123
A
2G2HA_P16
(ABL1)
TK
PD166326
I
89
70
123
89
70
123
A
1AGWA_SU2
(FGFR1)
TK
SU 4984
I
77
81
111
77
81
111
A
2HZIA_JIN
(ABL1)
TK
PD180970
I
90
77
120
90
77
120
B
15
2ITOA_IRE
(EGFR)
TK
Gefitinib
I
69
313
99
B
2ITOA_IRE
(EGFR)
TK
Gefitinib
I
69
313
99
69
313
99
B
2ITYA_IRE
(EGFR)
TK
Gefitinib
I
69
313
99
69
313
99
B
2ITQA_STU
(EGFR)
TK
staurosporine
I
80
85
106
80
85
106
B
2ITZA_IRE
(EGFR)
TK
Gefitinib
I
69
313
99
69
313
99
B
2ITUA_STU
(EGFR)
TK
staurosporine
I
80
85
106
80
85
106
B
2ITWA_STU
(EGFR)
TK
staurosporine
I
80
85
106
80
85
106
B
2VWUA_7X1
(EPHB4)
TK
Chlorobenzod...
I
77
287
111
77
287
111
B
2WTWA_ZZL
(AURKA)
TK
MLN8054
I
35
24
70
35
24
70
B
3H10A_97B
(AURKA)
TK
MLN8054
I
39
88
82
39
88
82
B
2C6EA_HPM
(AURKA)
TK
HPM
I
44
237
90
44
237
90
B
2X9FA_X9F
(EPHB4)
TK
X9F
I
46
19
86
46
19
86
B
3EFWA_AK8
(AURKA)
TK
3efw
I
100
59
105
100
59
105
B
2BMCA_MPY
(AURKA)
TK
PHA-680632
I
107
108
107
107
108
107
B
3F5PA_741
(IGF1R)
TK
3-cyanoquino...
I
60
123
81
60
123
81
B
3EKNA_GS3
(INSR)
TK
pyrrolo[2,3-...
I
90
215
127
90
215
127
E
21
3G0EA_B49
(KIT)
TK
Sunitinib
I
37
40
78
E
3G0EA_B49
(KIT)
TK
Sunitinib
I
37
40
78
37
40
78
E
1YWNA_LIF
(KDR)
TK
AC1NS1DP
II
17
49
42
17
49
42
E
3G0FA_B49
(KIT)
TK
Sunitinib
I
37
40
78
37
40
78
E
2OFVA_242
(LCK)
TK
2ofv
II
28
181
65
28
181
65
E
1UWHA_BAX
(BRAF)
TK
Sorafenib
II
19
39
35
19
39
35
E
1UWJA_BAX
(BRAF)
TK
Sorafenib
II
19
39
35
19
39
35
E
2OG8A_1N8
(LCK)
TK
1N8
II
35
190
69
35
190
69
E
3Q96A_0NF
(BRAF)
TK
(2s)-N-[3-(2...
II
19
21
35
19
21
35
E
3QRIA_919
(ABL1)
TK
Sorafenib
II
23
18
54
23
18
54
E
3QRJA_919
(ABL1)
TK
Sorafenib
II
23
18
54
23
18
54
E
3EWHA_K11
(KDR)
TK
k11
II
17
27
46
17
27
46
E
3BE2A_RAJ
(KDR)
TK
RAJ
II
19
249
47
19
249
47
E
3CS9A_NIL
(ABL1)
TK
Nilotinib
II
19
132
48
19
132
48
E
3C7QA_XIN
(KDR)
TK
BIBF1120
I
25
56
50
25
56
50
E
3DKOA_IHZ
(EPHA7)
TK
DB07970
II
7
11
15
7
11
15
E
3C1XA_CKK
(MET)
TK
AZD_1152HQPA
II
19
77
36
19
77
36
E
3DZQA_IFC
(EPHA3)
TK
Nilotinib
II
9
30
22
9
30
22
E
3LQ8A_88Z
(MET)
TK
AZD_1152HQPA
II
19
71
36
19
71
36
E
2E2BA_406
(ABL1)
TK
Bafetinib
II
18
200
48
18
200
48
E
2OO8X_RAJ
(TEK)
TK
RAJ
II
16
246
36
16
246
36
E
2OSCA_MUH
(TEK)
TK
2osc
II
17
136
36
17
136
36
F
2
3FZTA_4JZ
(PTK2B)
TK
PF-4618433
II
9
20
24
F
3FZTA_4JZ
(PTK2B)
TK
PF-4618433
II
9
20
24
9
20
24
F
2P4IA_MR9
(TEK)
TK
2p4i
II
3
52
10
3
52
10